Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
382
382 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- QEL-001HLA-A2 CAR-TregPhase 21 trial
Quell Therapeutics Limited · Rejection; Transplant, Liver, Liver Failure, Liver Diseases
- QL2401Phase 21 trial
Qilu Pharmaceutical Co., Ltd. · Metabolic Dysfunction-associated Steatohepatitis (MASH)
- RABI-767Phase 21 trial
Panafina, Inc. · Acute Pancreatitis
- Reference : ondansetronPhase 21 trial
Helsinn Healthcare SA · Nausea and Vomiting Chemotherapy-Induced, Nausea Post Chemotherapy
- RO6874281Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- RP-001Phase 21 trial
Recurv Pharma Inc · Advanced Malignancies, Oncology, Colorectal Cancer
- RR001Phase 21 trial
EIR Biotherapies s.r.l. · Locally Advanced Pancreatic Adenocarcinoma
- SKB315Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Gastroesophageal Junction Adenocarcinoma
- SL-28Phase 21 trial
Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic
- SNP-610Phase 21 trial
Sinew Pharma Inc. · NASH - Nonalcoholic Steatohepatitis
- SNS-101anti-VISTAPhase 21 trial
Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer
- SPH5030Phase 21 trial
Shanghai Pharmaceuticals Holding Co., Ltd · Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
- SYS6062Phase 21 trial
CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Gastric Cancer (GC), Colorectal Cancer (CRC)
- Tacrolimus prolonged releasePhase 21 trial
Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation
- TAK-101Phase 21 trial
Takeda · Celiac Disease
- TAK-242Phase 21 trial
Yaqrit Ltd · Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic
- TER-2013Phase 21 trial
Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer
- TGM-312-SC01Phase 21 trial
Tangram Therapeutics Plc · Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis
- TH9619Phase 21 trial
One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck
- TQA2225AP025Phase 21 trial
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Non-alcoholic Steatohepatitis
- TRYP-0082Phase 21 trial
TRYP Therapeutics · Irritable Bowel Syndrome
- VB15010Phase 21 trial
Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast
- VMD-928Phase 21 trial
VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer
- vopimetostatPhase 21 trial
Tango Therapeutics, Inc. · PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
- VSA006Phase 21 trial
Visirna Therapeutics HK Limited · Nash
- WEF-001Phase 21 trial
Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer
- XER-001Phase 21 trial
Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma
- XYA02Phase 21 trial
XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer
- Y101DPhase 21 trial
Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma
- YL-13027Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer
- ZED1227Phase 21 trial
Dr. Falk Pharma GmbH · Celiac Disease
- ZSP1601Phase 21 trial
Guangdong Raynovent Biotech Co., Ltd · Nonalcoholic Steatohepatitis (NASH)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.